Long-term efficacy of hepatitis B vaccine, booster policy, and impact of hepatitis B virus mutants.
The long-term efficacy of hepatitis B vaccine, long-term effectiveness of hepatitis B immunisation programmes, immune memory induced by hepatitis B vaccine, current booster policies, and impact of hepatitis B virus mutants on immunisation programmes were reviewed at the Viral Hepatitis Prevention Board (VHPB) meeting in Sevilla, Spain, March 2004. The main focus was on universal vaccination programmes with data being presented from Italy, Saudi Arabia, Singapore, Spain, Taiwan, Thailand, The Gambia, and USA (Alaska).
Fitzsimons
David
D
World Health Organization, Via Appia 20, CH-1211 Geneva, Switzerland.
François
Guido
G
Hall
Andrew
A
McMahon
Brian
B
Meheus
André
A
Zanetti
Alessandro
A
Duval
Bernard
B
Jilg
Wolfgang
W
Böcher
Wulf Otto
WO
Lu
Sheng-Nan
SN
Akarca
Ulus
U
Lavanchy
Daniel
D
Goldstein
Susan
S
Banatvala
Jangu
J
Damme
Pierre Van
PV
D004279:DNA, Viral / Q000032:analysis; D006509:Hepatitis B / Q000453:epidemiology / Q000235:genetics / Q000276:immunology / Q000517:prevention & control*; D006510:Hepatitis B Antibodies / Q000032:analysis; D017325:Hepatitis B Vaccines / Q000627:therapeutic use*; D006801:Humans; D017589:Immunization Programs / Q000639:trends*; D007117:Immunization, Secondary / Q000639:trends*; D007156:Immunologic Memory / Q000276:immunology*; D009154:Mutation; D013995:Time
D004279:DNA, Viral; D006510:Hepatitis B Antibodies; D017325:Hepatitis B Vaccines